NCT04249440View on ClinicalTrials.gov

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

CompletedOBSERVATIONAL
Enrollment

1,067

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

December 30, 2019

Study Completion Date

March 30, 2020

Conditions
Breast CancerHER2Preoperative Systemic Treatment
Interventions
PROCEDURE

Preoperative systemic treatment

neoadjuvant chemotherapy combined with trastuzumab as preoperative systemic treatment

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT04249440 - Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer | Biotech Hunter | Biotech Hunter